Anuh Pharma Limited (NSE:ANUHPHR)
210.70
+2.65 (1.27%)
At close: Jun 27, 2025, 3:30 PM IST
Anuh Pharma Revenue
In the fiscal year ending March 31, 2025, Anuh Pharma had annual revenue of 6.62B INR with 2.24% growth. Anuh Pharma had revenue of 1.98B in the quarter ending March 31, 2025, with 20.90% growth.
Revenue
6.62B
Revenue Growth
+2.24%
P/S Ratio
1.60
Revenue / Employee
37.80M
Employees
175
Market Cap
10.56B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 6.62B | 145.11M | 2.24% |
Mar 31, 2024 | 6.47B | 1.20B | 22.66% |
Mar 31, 2023 | 5.27B | 408.40M | 8.39% |
Mar 31, 2022 | 4.87B | 546.86M | 12.66% |
Mar 31, 2021 | 4.32B | 1.25B | 40.72% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 272.67B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Mankind Pharma | 122.07B |
Aurobindo Pharma | 317.24B |
Fortis Healthcare | 77.83B |